p16INK4a promoter methylation and protein expression in breast fibroadenoma and carcinoma

No abstract is available for this paper.

• Publication year

  2005

• Venue

  International Journal of Cancer

• Publication date

  2005-04-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.20771PMID 15578730
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Electron microscopy evidence that cytoplasmic localization of the p16INK4A “nuclear” cyclin-dependent kinase inhibitor (CKI) in tumor cells is specific and not an artifact. A study in non-small cell lung carcinomas

  2004cited by this paper
• Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms

  2003cited by this paper
• Methylation of p16(INK4a) promoters occurs in vivo in histologically normal human mammary epithelia.

  2003cited by this paper
• MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland

  2002cited by this paper
• Expression and methylation of CASP8 in neuroblastoma: Identification of a promoter region

  2002cited by this paper
• Quantitative assessment of promoter hypermethylation during breast cancer development.

  2002cited by this paper
• p16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy

  2001cited by this paper
• Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia

  2001cited by this paper
• Methylation-independent silencing of the p73 gene in neuroblastoma

  2000cited by this paper
• INK4a gene expression and methylation in primary breast cancer: overexpression of p16INK4a messenger RNA is a marker of poor prognosis.

  2000cited by this paper
• Predicting lung cancer by detecting aberrant promoter methylation in sputum.

  2000cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways.

  1998cited by this paper
• Retinoblastoma and p16 proteins in mammary carcinoma: Their relationship to cyclin D1 and histopathological parameters

  1998cited by this paper
• p16INK4A Participates in a G1 Arrest Checkpoint in Response to DNA Damage

  1998cited by this paper
• Aberrant cytoplasmic expression of the p16 protein in breast cancer is associated with accelerated tumour proliferation.

  1998cited by this paper
• The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53.

  1998cited by this paper
• Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2.

  1998cited by this paper
• The p16INK4a/CDKN2A tumor suppressor and its relatives.

  1998cited by this paper
• Alterations in DNA methylation: a fundamental aspect of neoplasia.

  1998cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• High frequency of aberrant p16(INK4A) expression in human breast cancer.

  1996cited by this paper
• Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

  1996cited by this paper
• Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers.

  1995cited by this paper
• Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition

  1995cited by this paper
• Oncogenic aberrations of p16INK4/CDKN2 and cyclin D1 cooperate to deregulate G1 control.

  1995cited by this paper
• Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors.

  1995cited by this paper
• Mutational analysis of CDKN2 (MTS1/p16ink4) in human breast carcinomas.

  1994cited by this paper
• A cell cycle regulator potentially involved in genesis of many tumor types.

  1994cited by this paper
• Histologic types of benign breast disease and the risk for breast cancer

  1992cited by this paper
• HER-2/neu oncogene expression, DNA ploidy and proliferation index in breast cancer.

  1992cited by this paper
• Research on infertility: definition makes a difference. The Cancer and Steroid Hormone Study Group.

  1989cited by this paper
• A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

  1988cited by this paper
• A COMPARATIVE STUDY OF TWO DIVERSE STRAINS OF GIARDIA LAMBLIA STILES, 1915

  1930cited by this paper

• DNA Methylation and Transcript Variant Analysis of CDKN2A Exon 2 Despite High Sequence Identity with CDKN2B Exon 2

  2025cites this paper
• Association between p16INK4A Expression and a Treatment Response to CDK4/6 Inhibitor in Advanced Breast Carcinoma.

  2025cites this paper
• Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment

  2025cites this paper
• Cytoplasmic Expression of p16 Is Associated with Carcinoma Breast: It Is Not an Artifact

  2024cites this paper
• p16 Expression in Laryngeal Squamous Cell Carcinoma: A Surrogate or Independent Prognostic Marker?

  2024cites this paper
• Prevalence of HPV Infection and p16INK4a Overexpression in Surgically Treated Laryngeal Squamous Cell Carcinoma

  2022cites this paper
• Breast Cancer and p16: Role in Proliferation, Malignant Transformation and Progression

  2021cites this paper
• A pilot study on DNA hypermethylation status in promoter region of P16 gene in patients with sporadic breast cancer.

  2021cites this paper
• Cytoplasmic translocation of p16 could be associated with CDK4 to promote progression of breast cancer

  2020cites this paper
• P16INK4A Immunohistochemistry as a Gold Standard for Cervical Cancer and Precursor Lesions Screening

  2020cites this paper
• Indole Derivative Interacts with Estrogen Receptor Beta and Inhibits Human Ovarian Cancer Cell Growth

  2020cites this paper
• Expression of COX-2, p16, and Ki67 in the range from normal breast tissue to breast cancer.

  2020cites this paper
• Targeting P16INK4A in uterine serous carcinoma through inhibition of histone demethylation

  2019cites this paper
• Epigenetic modulation of BRCA‐1 and MGMT genes, and histones H4 and H3 are associated with breast tumors

  2019cites this paper
• Quantitative assessment of aberrant P16INK4a methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets

  2018cites this paper
• Aberrant methylation‐induced dysfunction of p16 is associated with osteoblast activation caused by fluoride

  2018cites this paper
• Aberrant expression of p16INK4a in human cancers - a new biomarker?

  2018cites this paper
• Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients

  2017cites this paper
• P16 overexpression in BRAF-mutated gastrointestinal stromal tumors

  2017cites this paper
• Stromal p16 Overexpression in Adult Granulosa Cell Tumors of the Ovary.

  2017cites this paper
• Ginsenoside Rh2 epigenetically regulates cell-mediated immune pathway to inhibit proliferation of MCF-7 breast cancer cells

  2017cites this paper
• The stem cell renewal and DNA damage response pathways are frequently altered in fibroepithelial tumors of breast in Indian patients.

  2016cites this paper
• Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer

  2016cites this paper
• Genomic Changes in Normal Breast Tissue in Women at Normal Risk or at High Risk for Breast Cancer

  2016cites this paper
• Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast.

  2015cites this paper
• Dysregulation of the Rb pathway in recurrent pleomorphic adenoma of the salivary glands

  2015cites this paper
• On the Clinical Importance of Benign Breast Disease: Causal Intermediary or Susceptibility Marker?

  2015cites this paper
• p16INK4a expression in retinoblastoma: a marker of differentiation grade

  2014cites this paper
• Schwannomas, benign tumors with a senescent phenotype.

  2014cites this paper
• p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma.

  2014cites this paper
• Aberrant promoter CpG methylation and its translational applications in breast cancer

  2013cites this paper
• Global and gene-specific promoter methylation analysis in primary hyperparathyroidism

  2013cites this paper
• Methylation and Immunoexpression of p16INK4a Tumor Suppressor Gene in Primary Breast Cancer Tissue and Their Quantitative p16INK4a Hypermethylation in Plasma by Real-Time PCR

  2012cites this paper
• 5 Intraepithelial Neoplasia of Breast

  2012cites this paper
• p16 promoter hypermethylation is associated with increased breast cancer risk.

  2012cites this paper
• Intraepithelial Neoplasia of Breast

  2012cites this paper
• p16Ink4a overexpression in cancer: a tumor suppressor gene associated with senescence and high-grade tumors

  2011cites this paper
• Aberrant DNA methylation of cancer-related genes in giant breast fibroadenoma: a case report

  2011cites this paper
• Update on the molecular profile of the MDA-MB-453 cell line as a model for apocrine breast carcinoma studies.

  2011cites this paper
• Aberrant protein expression and promoter methylation of p16 gene are correlated with malignant transformation of salivary pleomorphic adenoma.

  2011cites this paper
• Gene Methylation in Breast Ductal Fluid from BRCA1 and BRCA2 Mutation Carriers

  2010cites this paper
• Outcome prediction and risk assessment by quantitative pyrosequencing methylation analysis of the SFN gene in advanced stage, high‐risk, neuroblastic tumor patients

  2010cites this paper
• DNA methylation epigenotypes in breast cancer molecular subtypes

  2010cites this paper
• DNA methylation profiling of phyllodes and fibroadenoma tumours of the breast

  2010cites this paper
• Pathological and molecular characteristics distinguishing contralateral metastatic from new primary breast cancer.

  2010cites this paper
• Different intracellular compartmentalization of TA and DeltaNp73 in non-small cell lung cancer.

  2009cites this paper
• Epigenetic alteration of p16INK4a gene in dedifferentiation of liposarcoma.

  2009cites this paper
• Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.

  2009cites this paper
• Promoter methylation and the detection of breast cancer

  2009cites this paper
• Analysis of DNA Methylation of Multiple Genes in Microdissected Cells From Formalin-fixed and Paraffin-embedded Tissues

  2009cites this paper
• ESTUDO DO BIOMARCADOR P16 NO CARCINOMA DE MAMA DE MULHERES SUBMETIDAS À ENDOCRINOTERAPIA PRIMÁRIA DE CURTA DURAÇÃO COM TAMOXIFENO E ANASTROZOL

  2009cites this paper
• Epigenetic silencing of the p16(INK4a) tumor suppressor is associated with loss of CTCF binding and a chromatin boundary.

  2009cites this paper
• p16, Cyclin D1, Ki-67, and AMACR as Markers for Dysplasia in Barrett Esophagus

  2008cites this paper
• Quantitative detection of methylated ESR1 and 14-3-3-σ gene promoters in serum as candidate biomarkers for diagnosis of breast cancer and evaluation of treatment efficacy

  2008cites this paper
• Methylation of CpG islands of p16(INK4a) and cyclinD1 overexpression associated with progression of intraductal proliferative lesions of the breast.

  2008cites this paper
• Cell cycle machinery: links with genesis and treatment of breast cancer.

  2008cites this paper
• The significance of immunohistochemical expression of Ki-67, p53, p21, and p16 in meningiomas tissue arrays.

  2008cites this paper
• Promoter hypermethylation of p16INK4A, p14ARF, CyclinD2 and Slit2 in serum and tumor DNA from breast cancer patients.

  2007cites this paper
• Morphologically Normal-Appearing Mammary Epithelial Cells Obtained from High-Risk Women Exhibit Methylation Silencing of INK4a/ARF

  2007cites this paper
• Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues.

  2007cites this paper
• Morphologically Normal-AppearingMammary Epithelial Cells Obtained from High-RiskWomen Exhibit Methylation Silencing of INK 4 a / ARF

  2007cites this paper
• Precursors and preinvasive lesions of the breast: the role of molecular prognostic markers in the diagnostic and therapeutic dilemma

  2007cites this paper
• Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas

  2007cites this paper
• Correlation between CpG methylation profiles and hormone receptor status in breast cancers

  2007cites this paper
• Association between Promoter Hypermethylation of the p16INK4a and hTERT Genes and Their Protein Expressions in Human Breast Cancer

  2007cites this paper
• DNA Hypermethylation Patterns Detected in Serum as a Tool for Early Breast Cancer Diagnosis

  2007cites this paper
• Meth-DOP-PCR: an assay for the methylation profiling of trace amounts of DNA extracted from bodily fluids

  2006cites this paper
• Pattern of expression of genes linked to epigenetic silencing in human breast cancer.

  2006cites this paper
• Modulation of cell cycle components by epigenetic and genetic events.

  2005cites this paper
• Gene Environment Interactions in Women With Breast and Secondary Lung Cancer

  2005cites this paper
• Distinct CpG methylation profiles characterize different clinical groups of neuroblastic tumors

  2005cites this paper